Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/2/2021
SIETES contiene 93212 citas

 1 a 20 de 163 siguiente >>
Presentar resultados
Seleccionar todas
2. Cita con resumen
Ledley FD, McCoy SS, Vaughan G, Cleary EG. Profitability of large pharmaceutical companies compared with other large public companies. JAMA 2020;323:3 de marzo. [Ref.ID 103560]
3.Enlace a cita original Cita con resumen
García PJ. Corruption in global health: the open secret. Lancet 2019;394:7 de diciembre. [Ref.ID 103221]
5. Cita con resumen
Thielking M. FDA cracks down on ‘vaginal rejuvenation’ devices, citing potential for serious harm. STAT Daily Recap 2018:30 de julio. [Ref.ID 102728]
6.Enlace a cita original Cita con resumen
Hernández-Aguado I, Chilet-Rosell E. Pathways of undue influence in health policy-making: a main actor's perspective. J Epidemiol Community Health 2018;72:154-9. [Ref.ID 102446]
7. Cita con resumen
Anónimo. PhRMA, BIO increased spending on federal lobbying. DIA Daily 2017:1. [Ref.ID 101918]
8. Cita con resumen
Anónimo. FDA approves guselkumab for treatment of plaque psoriasis. DIA Daily 2017:2. [Ref.ID 101909]
9. Cita con resumen
11.Enlace a cita original Cita con resumen
Campsall P, Colizza K, Straus S, Stelfox HT. Financial relationships between organizations that produce clinical practice guidelines and the biomedical industry: a Cross-sectional study. PLOS Medicine 2016:31 de mayo. [Ref.ID 100344]
12. Cita con resumen
Naci H, Carter AW, Mossialos E. Why the drug development pipeline is not delivering better medicines. BMJ 2015;351:h5542. [Ref.ID 99639]
14. Cita con resumen
Allen K, Pearson-Stuttard J, Hooton W, Diggle P, Capewell S, O’Flaherty M. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study. BMJ 2015;351:h4583. [Ref.ID 99541]
15.Tiene citas relacionadas Cita con resumen
Grey A, Bolland M. Web of industry, advocacy, and academia in the management of osteoporosis. BMJ 2015;351:h3170. [Ref.ID 99391]
16. Cita con resumen
Anónimo. Traité commercial États-Unis-Union européenee: menaces sur la santé. Prescrire 2015;35:218-9. [Ref.ID 98927]
17. Cita con resumen
MacMahon S, Perkovic V, Patel A. Industry-sponsored clinical trials in emerging markets: time to review the terms of engagement. JAMA 2013;310:907-8. [Ref.ID 96051]
18. Cita con resumen
Cohen D. Medtronic submits full data on spinal protein to independent scrutiny. BMJ 2011;343:d5484. [Ref.ID 91895]
19. Cita con resumen
Turone F. Homoeopathy multinational Boiron threatens amateur Italian blogger. BMJ 2011;343:d5197. [Ref.ID 91892]
20. Cita con resumen
Azhar GS. Access to information is crucial for science. Lancet 2011;377:1404. [Ref.ID 90538]
Seleccionar todas
 1 a 20 de 163 siguiente >>